• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Oncology Pharmaceuticals Market in India 2012 Product Image

Oncology Pharmaceuticals Market in India 2012

  • Published: April 2012
  • Region: India
  • 71 Pages
  • Netscribes (India) Pvt Ltd

FEATURED COMPANIES

  • Aventis Pharma Limited
  • Cipla Limited
  • Merck Limited
  • Novartis India Limited
  • Pfizer Limited
  • MORE

Oncology pharmaceuticals market in India, a leading segment of the overall pharmaceuticals market is the fourth largest in volume and eighth largest in value in the global market. Since cancer is the second largest cause of death in the country, the Indian market is characterized by a huge demand for cancer drugs. It is a highly fragmented market with a large number of foreign and domestic players. The huge increase in the number of cancer cases, specially in lung cancer and breast cancer cases; changes in the cancer treatment scenario, development of alternative cancer therapies, increased cancer health insurance coverage and increasing amount of foreign direct investment (FDI) is helping the market to grow. The Indian Government, on its part is taking initiatives to work out public-private partnership projects (PPP) and reduce the essential drug prices. The market is expected to exhibit steady growth over the next few years.

The report begins with the market overview section which provides an insight into the global market, highlighting the market size and growth. It then moves onto the Indian market, with a focus on market size and growth. It also provides import and export READ MORE >

Page 1: Executive summary

Market Overview

Page 2: Global Oncology Pharmaceuticals Market – Overview, Size & Growth (Value: 2007 and 2013e),

Page 3: Indian Oncology Pharmaceuticals Market- Overview, Size & Growth (Value: 2010-2016e)

Page 4: Overview of cancer prevalence in India

Page 5-6: EXIM statistics of oncology pharmaceuticals (Value: 2006-07 to 2010-11)

Drivers & Challenges

Page 7: Summary

Page 8-12: Drivers

Page 13-15: Challenges

Government Initiatives

Page 16: Summary

Page 12- 21: Government Initiatives

Market value chain, regulation and patents

Page 22: Pharmaceutical value chain

Page 23: Phases of clinical trials

Page 24: Indian government functions in licensing and registration of pharmaceuticals

Page 25: Indian drug regulatory frameworks

Page 26- 27: List of patent approvals by US FDA

Page 28: List of oncology drug marketing approvals in India

Competition

Page 29: Market Competition – Porter’s Five Forces Analysis

Page 30- 63: Major public players

Page 58- 69: Major private players

Page 70: Recent Developments

Strategic Recommendation

Page 71: Strategic Recommendations

- Aventis Pharma Limited
- Cipla Limited
- Dr. Reddy's Laboratories Limited
- Fresenius Kabi Oncology Limited
- GlaxoSmithKline Pharmaceuticals Limited
- Novartis India Limited
- Merck Limited
- Pfizer Limited
- Ranbaxy Laboratories Limited
- Sun Pharmaceutical Industries Limited
- Cytogen Pharmaceuticals India Private Limited
- Johnson and Johnson Limited
- Roche Pharmaceuticals Private Limited

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos